{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T16:19:42Z","timestamp":1785860382428,"version":"3.56.0"},"reference-count":21,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,3]]},"abstract":"<jats:sec>\n                    <jats:title>Introduction:<\/jats:title>\n                    <jats:p>PReferentially expressed Antigen in Melanoma (PRAME) antibody is a crucial biomarker for differentiating melanoma from benign lesions. However, its diagnostic value in dysplastic nevi (DN) remains controversial.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objectives:<\/jats:title>\n                    <jats:p>This study investigates its diagnostic potential and clinicopathologic correlations.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>PRAME was immunohistochemically assessed in 115 low-grade DN (LG-DN) and 18 high-grade DN (HG-DN). Staining was scored from 0 (no staining) to 4+ (75% or more). The relationship of PRAME expression with age, sex, location, and histologic grade was examined.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      We analyzed 133 DNs from 107 patients. Of these, 49.5% were female patients and 50.5% were male patients, with a mean age of 36.6 years (range 7\u201391). Female patients presented lesions at a younger age than male patients (31.7 vs. 40.6 years;\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt; 0.001). Histologic grade increased with age (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.017). Most lesions were located on the trunk (51.9% back, 27.1% chest) followed by the head and neck (7.5%). PRAME expression was score 0 in 84.3% of LG-DN and 77.8% of HG-DN. Score 4+ expression was observed in 7% of LG-DN and in 11.2% of HG-DN. Although a trend toward higher PRAME positivity in HG-DN was noted, it did not reach statistical significance. No correlations were found between PRAME expression and age, sex, location.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>The findings indicate that PRAME expression is not associated with histologic grade or clinical parameters in DN, suggesting that this marker may have limited prognostic or diagnostic value in these lesions. These results need to be supported by larger sample-sized and comparative studies.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/dad.0000000000003203","type":"journal-article","created":{"date-parts":[[2025,12,26]],"date-time":"2025-12-26T16:00:14Z","timestamp":1766764814000},"page":"197-201","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["Evaluation of Preferentially Expressed Antigen in Melanoma Expression and Epidemiologic Features in Dysplastic Nevi: A Comparative Analysis of Low- and High-Grade Lesions"],"prefix":"10.1097","volume":"48","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0994-2294","authenticated-orcid":false,"given":"Hazal","family":"\u0130zol","sequence":"first","affiliation":[{"name":"Department of Pathology, \u0130stanbul Ba\u015fak\u015fehir \u00c7am and Sakura City Hospital, \u0130stanbul, Turkey;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G\u00fcl\u015fah","family":"Kolak G\u00f6z\u00fck\u00fc\u00e7\u00fck","sequence":"additional","affiliation":[{"name":"Department of Pathology, \u0130stanbul Ba\u015fak\u015fehir \u00c7am and Sakura City Hospital, \u0130stanbul, Turkey;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sidar","family":"Ba\u011fbudar","sequence":"additional","affiliation":[{"name":"Department of Pathology, \u0130stanbul University Faculty of Medicine, \u0130stanbul, Turkey; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Per\u00e7in","family":"Ca\u015fkan","sequence":"additional","affiliation":[{"name":"Department of Plastic and Reconstructive Surgery, \u0130stanbul Ba\u015fak\u015fehir \u00c7am and Sakura City Hospital, \u0130stanbul, Turkey."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatmag\u00fcl","family":"Ku\u015fku \u00c7abuk","sequence":"additional","affiliation":[{"name":"Department of Pathology, \u0130stanbul Ba\u015fak\u015fehir \u00c7am and Sakura City Hospital, \u0130stanbul, Turkey;"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2025,12,26]]},"reference":[{"key":"R1-20260420","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1111\/j.1365-2559.2009.03450.x","article-title":"Dysplastic naevi: an update","volume":"56","author":"Elder","year":"2010","journal-title":"Histopathology"},{"key":"R2-20260420","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jaad.2022.04.068","article-title":"Dysplastic nevus part I: historical perspective, classification, and epidemiology","volume":"88","author":"Drozdowski","year":"2023","journal-title":"J Am Acad Dermatol"},{"key":"R3-20260420","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1097\/CMR.0000000000000113","article-title":"Melanoma density and relationship with the distribution of melanocytic naevi in an Italian population: a GIPMe study\u2014The Italian multidisciplinary group on melanoma","volume":"25","author":"Chiarugi","year":"2015","journal-title":"Melanoma Res"},{"key":"R4-20260420","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.ejca.2004.10.015","article-title":"Meta-analysis of risk factors for cutaneous melanoma: I. Common and atypical naevi","volume":"41","author":"Gandini","year":"2005","journal-title":"Eur J Cancer"},{"key":"R5-20260420","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1097\/01.MP.0000082394.91761.E5","article-title":"Grading of atypia in nevi: correlation with melanoma risk","volume":"16","author":"Arumi-Uria","year":"2003","journal-title":"Mod Pathol"},{"key":"R7-20260420","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1111\/cup.14165","article-title":"Analysis of interobserver reproducibility in grading dysplastic nevi: results of the application of the 2018 world health organization grading criteria","volume":"49","author":"Aydin Ulgen","year":"2022","journal-title":"J Cutan Pathol"},{"key":"R8-20260420","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/S1074-7613(00)80426-4","article-title":"Characterization of an antigen that is recognized on a melanoma showing partial HLA loss by CTL expressing an NK inhibitory receptor","volume":"6","author":"Ikeda","year":"1997","journal-title":"Immunity"},{"key":"R9-20260420","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1016\/j.cell.2005.07.003","article-title":"The human tumor antigen PRAME is a dominant repressor of retinoic acid receptor signaling","volume":"122","author":"Epping","year":"2005","journal-title":"Cell"},{"key":"R10-20260420","doi-asserted-by":"crossref","first-page":"e12770","DOI":"10.1111\/cpr.12770","article-title":"The role of the cancer testis antigen PRAME in tumorigenesis and immunotherapy in human cancer","volume":"53","author":"Xu","year":"2020","journal-title":"Cell Prolif"},{"key":"R11-20260420","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1097\/PAS.0000000000001134","article-title":"PRAME expression in melanocytic tumors","volume":"42","author":"Lezcano","year":"2018","journal-title":"Am J Surg Pathol"},{"key":"R12-20260420","doi-asserted-by":"crossref","first-page":"4264","DOI":"10.3390\/cancers16244264","article-title":"The importance of early detection and prevention of atypical skin lesions and other melanoma risk factors in a younger population","volume":"16","author":"Karp","year":"2024","journal-title":"Cancers (Basel)"},{"key":"R13-20260420","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1097\/PAS.0000000000001393","article-title":"Immunohistochemistry for PRAME in the distinction of nodal nevi from metastatic melanoma","volume":"44","author":"Lezcano","year":"2020","journal-title":"Am J Surg Pathol"},{"key":"R14-20260420","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1097\/DAD.0000000000002354","article-title":"Staged excision of Lentigo maligna of the head and neck: assessing surgical excision margins with Melan A, SOX10, and PRAME immunohistochemistry","volume":"45","author":"de Wet","year":"2023","journal-title":"Am J Dermatopathol"},{"key":"R15-20260420","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1111\/his.14312","article-title":"PRAME immunohistochemistry as an adjunct for diagnosis and histological margin assessment in lentigo maligna","volume":"78","author":"Gradecki","year":"2021","journal-title":"Histopathology"},{"key":"R16-20260420","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.3390\/ijms25031582","article-title":"PRAME updated: diagnostic, prognostic, and therapeutic role in skin cancer","volume":"25","author":"Cassalia","year":"2024","journal-title":"Int J Mol Sci"},{"key":"R17-20260420","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/s00428-023-03720-5","article-title":"Shedding light on PRAME expression in dysplastic nevi: a cohort study","volume":"485","author":"Innocenti","year":"2024","journal-title":"Virchows Arch"},{"key":"R18-20260420","doi-asserted-by":"crossref","first-page":"155993","DOI":"10.1016\/j.prp.2025.155993","article-title":"The combined diagnostic value of 5-hmC and PRAME immunohistochemistry in melanocytic neoplasms","volume":"270","author":"Yu","year":"2025","journal-title":"Pathol Res Pract"},{"key":"R19-20260420","doi-asserted-by":"crossref","first-page":"3","DOI":"10.3390\/cancers14010003","article-title":"Shared gene expression and immune pathway changes associated with progression from nevi to melanoma","volume":"14","author":"Borden","year":"2021","journal-title":"Cancers (Basel)"},{"key":"R20-20260420","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1111\/cup.13818","article-title":"PRAME expression in melanocytic proliferations with intermediate histopathologic or spitzoid features","volume":"47","author":"Raghavan","year":"2020","journal-title":"J Cutan Pathol"},{"key":"R21-20260420","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.3390\/diagnostics14182015","article-title":"PRAME immunohistochemistry in thin melanomas compared to melanocytic nevi","volume":"14","author":"Zbora\u015f","year":"2024","journal-title":"Diagnostics"},{"key":"R22-20260420","doi-asserted-by":"crossref","first-page":"2089324","DOI":"10.1080\/09546634.2022.2089324","article-title":"Management of dysplastic nevi: a 6 year follow-up survey assessing practice trends among US dermatologists","volume":"34","author":"Brownstone","year":"2023","journal-title":"J Dermatolog Treat"}],"container-title":["The American Journal of Dermatopathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/DAD.0000000000003203","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T15:23:53Z","timestamp":1785857033000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/DAD.0000000000003203"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,26]]},"references-count":21,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/dad.0000000000003203","relation":{},"ISSN":["0193-1091","1533-0311"],"issn-type":[{"value":"0193-1091","type":"print"},{"value":"1533-0311","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,26]]}}}